DNA vaccine candidate

Healthcare

DBT-BIRAC supported indigenously developed DNA Vaccine Candidate by Zydus Cadila, approved for Phase III clinical trials

SMEDesk - January 4, 2021

The Nation’s first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for conduct of the Phase III clinical trials. The candidate has been supported by...

- Advertisement -

spot_img

Latest News

UncategorizedSMEDesk - July 13, 2026

India and Australia Launch New Cyber and Technology Partnership

India and Australia have launched a new strategic partnership to deepen cooperation on cybersecurity, critical technologies and resilient supply...

- Advertisement -

spot_img

Uncategorized

Women-Led MSMEs Now Form 39% of India’s Registered Base

SMEDesk - July 13, 2026

MSME Assist

India and Mali Launch New Forum to Expand Trade, Investment and Business Cooperation

SMEDesk - July 6, 2026

MSME Assist

Government Mandates TReDS Settlement for CPSEs to Speed Up MSME Payments

SMEDesk - July 6, 2026

Industry Dynamics

MSME Commercial Credit Reaches Rs 65.8 Lakh Crore, But Only 41% of Enterprises Have Formal Access

SMEDesk - July 6, 2026